Retail sales grew 38% to $79 million while direct sales fell 5.4% to $145.3 million.
The company also reaffirmed its revenue guidance of $700 million to $715 million and EPS outlook of $0.81 to $0.86 for the fiscal year 2021. Analysts polled by Capital IQ are expecting $714.1 million in revenue and $0.85 in adjusted EPS.
Price: 14.36, Change: -0.02, Percent Change: -0.14
|Mainz Biomed Working With Dante Labs to Market Cance...|
|AT&T, Dish Network Enter Into Internet Distribution ...|
|Research Alert: CFRA Maintains Hold Opinion On Adss ...|
|Gain Therapeutics Files $100 Million Mixed Shelf|
|Agnico Eagle Mines to Invest Additional $1.4 Million...|